Clinical Trial Update: A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic of GSK1070806 After a Single Intravenous Dose in Healthy Male and Female Caucasian, Chinese and Japanese Participants Aged 18 to 65 Years of Age Inclusive [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of a single intravenous dose of GSK1070806 in healthy adults aged …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• GSK1070806

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED